WeVote

Bill

Bill

HB 1317

Patient's Right to Informed Health Care Choices Act and prohibitions against deceptive advertising; extend repealers on.

2025 Regular Session Introduced by Fred Shanks

Mississippi bill HB 1317 establishes informed consent requirements and bans deceptive health care advertising while extending certain regulatory repealer provisions. [Died in committee 2025]

Died In Committee
0
WeVote Research Nonpartisan
Bill Summary · HB 1317

Legislative bill overview

HB 1317 establishes patient rights regarding informed health care choices and creates prohibitions against deceptive advertising in health care contexts. The bill also extends certain repeal provisions, though the specific details of which repealer provisions are extended are not specified in the available information.

Why is this important

Health care advertising and informed consent directly affect how patients make medical decisions and whether they receive accurate information about treatments and providers. Clear standards around deceptive practices can protect vulnerable populations from misleading claims, while informed consent protections ensure patients understand their treatment options.

Potential points of contention

  • Scope of "deceptive advertising": Defining what constitutes deceptive health care advertising is subjective; disagreement may arise over whether certain marketing claims, supplements, or alternative treatments should be restricted
  • Patient autonomy vs. paternalism: Balancing informed consent requirements with concerns that excessive restrictions limit patients' freedom to pursue treatments they prefer, including alternative or experimental options
  • Implementation costs: Health care providers and advertisers may argue compliance requirements create administrative burdens and costs that get passed to consumers or affect service availability

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.